Pulmatrix, Inc. (PULM) Financials

PULM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 36.8 million 16.9 million
2023-06-30 31.4 million 7.9 million
2023-03-31 36.1 million 9.0 million
2022-12-31 41.0 million 9.8 million

PULM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.5 million 206000
2023-06-30 -5.0 million 255000
2023-03-31 -4.9 million 296000
2022-12-31 -5.1 million 279000

PULM Net Income

No data available :(

PULM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 21.3 million - 8.6 million
2023-06-30 25.8 million - 358000
2023-03-31 30.8 million - 779000
2022-12-31 35.6 million - 857000

PULM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 3.7 million
2023-06-30 3.7 million
2023-03-31 3.7 million
2022-12-31 3.4 million

PULM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 313000 4.0 million 1.7 million -
2023-06-30 58000 4.2 million 1.7 million -
2023-03-31 58000 3.9 million 2.2 million -
2022-12-31 9000 4.5 million 1.6 million -

PULM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.8 million 426000
2023-06-30 1.8 million 440000
2023-03-31 1.5 million 401000
2022-12-31 1.7 million 389000

PULM

Price: $1.96

52 week price:
1.55
3.14

Earnings Per Share: -4.44 USD

P/E Ratio: -0.40

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 23200

Ebitda: -4.2 million

Market Capitalization: 6.9 million

Links: